Results 151 to 160 of about 1,381,406 (265)

Toward Precision Therapeutics in Pulmonary Arterial Hypertension. [PDF]

JACC Basic Transl Sci
Hong J.
europepmc   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Factors associated with cardiovascular events after simultaneous liver–kidney transplant from the US Multicenter Simultaneous Liver–Kidney Transplant Consortium

Hepatology Communications, EarlyView., 2022
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo, Gonzalo Crespo, Dyanna Gregory, Jasmine Sinha, Jiaheng Xie, Min Zhang, John Magee, Pranab Barman, Yuval A. Patel, Aaron Schluger, Kara Walters, Scott Biggins, Natalia Filipek, Giuseppe Cullaro, Randi Wong, Jennifer C. Lai, Gabriel J. Perreault, Elizabeth C. Verna, Pratima Sharma, Lisa B. VanWagner   +19 more
wiley   +1 more source

Sorting Out Vasoreactivity in Pulmonary Arterial Hypertension With SNX29. [PDF]

Circ Res
Creager MD, Yu PB.
europepmc   +1 more source

Identification of pulmonary arterial hypertension patients with venous or capillary involvement. [PDF]

Am J Respir Crit Care Med
Andruska AM, Cruz-Utrilla A, Nossent EJ, Celant LR, Yang IY, Lyn R, Lai YKJ, Kudelko K, Sung Y, Spiekerkoetter E, De Jesus Perez V, Guo HH, Bogaard HJ, Escribano-Subias P, Zamanian RT, Sweatt AJ.   +15 more
europepmc   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Evolving profile and outcomes of patients with pulmonary arterial hypertension undergoing lung transplantation. [PDF]

JHLT Open
Pradère P, Luong MC, Le Pavec J, Issard J, Coiffard B, Renard S, Boulate D, Renaud-Picard B, Olland A, Villeneuve T, Demant X, Maury JM, Chatron E, Mitilian D, Dauriat G, Boucly A, Sitbon O, Jaïs X, Montani D, Humbert M, Fadel E, Mercier O, Horeau-Langlard D, Savale L.   +23 more
europepmc   +1 more source

Macitentan for the treatment of pulmonary arterial hypertension

, 2014
Cyrus A Kholdani,1 Wassim H Fares,2 Terence K Trow2 1Section of Pulmonary, Critical Care and Sleep Medicine, 2Yale Pulmonary Vascular Disease Program, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Yale ...
Fares WH, Trow TK, Kholdani CA
core  

Frailty in Pulmonary Arterial Hypertension: A Cohort Study. [PDF]

Ann Am Thorac Soc
Farley GJ, Prakash M, Palevsky HI, Smith KA, Minhas JK, Fritz JS, Pugliese SC, Feng R, Al-Naamani N.   +8 more
europepmc   +1 more source

Ambrisentan for the treatment of pulmonary arterial hypertension

, 2008
Brian Casserly1,3, James R Klinger2,31Division of Pulmonary Medicine, The Memorial Hospital of Rhode Island, Pawtucket, RI, USA; 2Division of Pulmonary Sleep and Critical Care Medicine, Rhode Island Hospital; 3Waren Alpert Medical School of Brown ...
Brian Casserly, James R Klinger
core